Navigation Links
Life Recovery Systems Study of Heart Attack With ThermoSuit(R) System
Date:3/11/2008

KINNELON, N.J., and ALEXANDRIA, La., March 11 /PRNewswire/ -- Life Recovery Systems, HD, LLC announced today approval by the Food and Drug Administration (FDA) of an Investigational Device Exemption (IDE) application to investigate rapid hypothermia treatment in combination with primary angioplasty to treat heart attacks.

Previous clinical data suggested early and rapid cooling before reperfusion therapy with primary angioplasty may potentially reduce infarct size post reperfusion. The study will enroll up to twenty patients at two institutions who present within six hours of symptom onset and require PCI to restore blood flow to the heart. Patients will receive hypothermia with the Life Recovery Systems ThermoSuit(R) non-invasive cooling system. Cooling will be performed in the emergency room within 60 minutes of arrival and cooling time is to be less than 30 minutes to avoid prolonging door-to-balloon time beyond 90 minutes.

The study is co-chaired by Dr. Paul McMullan and Dr. Christopher White, Chairman of Cardiology for Ochsner Health System in New Orleans, LA.

In the Cool MI I trial(1) a subset of patients with anterior infarctions and whose temperature at the time of reperfusion was below 35 degrees C (26% of all anterior MI's in the cooled group) had a significantly smaller infarction (9.3% of the left ventricular mass in the cooled population vs. 18.2% in the control group p=0.05) than the control group, said Dr. Paul McMullan.

The goal of this pilot study is to confirm the feasibility and efficacy of external thin film liquid cooling to achieve "target" temperature within 30 minutes or less, and to demonstrate ease of maintenance of target temperature for three hours following removal of the patient from ThermoSuit(R). Primary safety endpoints data will also be collected. If this trial successfully achieves it its endpoints, a larger prospective randomized trial will be conducted.

Life Recovery Systems is pleased to
'/>"/>

SOURCE Life Recovery Systems, HD, LLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
2. 4-Star Gen. Barry Mccaffrey, Former U.S. Drug Czar, to Keynote Recovery Happens! Rally for Treatment: Wed., Sept. 5, 11 Am, State Capitol West Steps, Sacramento
3. Treating depression may improve recovery of heart rate variability following coronary syndromes
4. Recovery Resources Collaborates with Two Nonprofit Agencies for Children of Alcoholics Outreach Program
5. Joint NJ/NY Rally for Addiction Recovery to Be Hub of Events Nationwide
6. CRN Announces Syndication Launch for Recovery Talk Network
7. Altarum Wins $7 Million Contract to Provide Technical Assistance to the Access to Recovery Program
8. The First Mega-Shelter Arrangement in Oregon Created for Major Disaster Response and Recovery
9. Eli Lilly and Company Aids California Recovery Effort
10. Substance abuse practitioners ask what is recovery?
11. Low Levels of Good Cholesterol May Slow Stroke Recovery

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)...TON, Nov. 7 USAction th... Care for America Act, which will make health care...panies accountable and increase access to health c...ion. ,, "Teddy Roosevelt, FDR and Harry Truman ...an Charney. "Today,s vote ranks among our country,...
(Date:11/8/2009)...raises House Passage of Health Care Reform Bill ,...re, improve coverage for all Americans ,, CHIC...United States House of Representatives passed by a...slation that would strengthen Medicare for seniors...t prices millions of Americans out of affordable h...
(Date:11/7/2009)...TON, Nov. 7 Karen Ignag...e Plans (AHIP), released the following statement t...plans strongly support comprehensive health care r...by proposing a complete overhaul of how health ins... guaranteed coverage, elimination of pre-existing ...
(Date:11/7/2009)...lyn T. Coleman (CT), David A. Cook (GA), Louis J. ...r (LA) Honored ,, CHICAGO, Nov. 7 /PRNewswire-...MA) today presented five medical society executive...ntributions to the goals and ideals of the medical...s semi-annual policy making meeting in Houston. ,...
(Date:11/7/2009)...: "Faithful Catholics have a responsibility to vig...te the status quo." ,, WASHINGTON, Nov. 7 /...esident Judie Brown released the following stateme...pport Speaker Nancy Pelosi,s Affordable Health Car...nt preserving the status quo for abortion is voted...
Breaking Medicine News(10 mins):Health News:AARP Illinois Key Vote News Alert 2Health News:AARP Illinois Key Vote News Alert 3Health News:AHIP Statement on House Passage of H.R. 3962 2Health News:AMA Honors Medical Society Executives 2Health News:Statement Regarding Cardinal Rigali's Memo Protecting the 'Status Quo' On Life 2
... 10 Training Services On,Demand, Inc. (TSOD: htt...kills,training for Ph.D.-level professionals in th...utes of Health (NIH) National Institute of Allergy...ted government professionals engage in,complex neg...
...10 Quest Diagnostics,Incorporated (NYSE: DGX ), ..., information and services, announced that it is s...Conference on Wednesday, November 12, 2008.,The Qu...r,revenue growth of greater than 8%, operating inc...
...to present results from Phase 1/2 Clinical Trial o...examethasone) on Tuesday,December 9, 2008 at 8:30a...c. (Nasdaq: KERX ) today announced that data from...iety of Hematology,(ASH), to be held in San Franci...
...ture performances by The 88 and Kreesha Turner, N...ed,that Joel Madden, UNICEF Ambassador, and Nicole...flake Lighting ceremony on Saturday, November 22 a...ere the UNICEF Snowflake and the 20 Baccarat chand...
...s Now Include GPS Mapping via Google Earth and,Com...and GPS Sensors, LAKE SUCCESS, N.Y., Nov. 10 Pol... rate monitoring and fitness assessment technology...t market., The RS800CX offers athletes an elevate...
...10 He will play a vital role in,Menicon,s expansi... Co., Ltd. announced the appointment of Jonathan J...gies & Operations, effective,November 10. Jacobson...Marketing, Director of International Sales, and,Di...
Other Medicine News:Health News:TSOD's Frank Whyte Provides Negotiation Skills Training to NIH Scientists 2Health News:Quest Diagnostics to Speak at the 2008 Credit Suisse Healthcare Conference 2Health News:Keryx Biopharmaceuticals' KRX-0401 (Perifosine) Data Selected for Oral Presentation at the 50th Annual Meeting of the American Society of Hematology 2Health News:Keryx Biopharmaceuticals' KRX-0401 (Perifosine) Data Selected for Oral Presentation at the 50th Annual Meeting of the American Society of Hematology 3Health News:Keryx Biopharmaceuticals' KRX-0401 (Perifosine) Data Selected for Oral Presentation at the 50th Annual Meeting of the American Society of Hematology 4Health News:Keryx Biopharmaceuticals' KRX-0401 (Perifosine) Data Selected for Oral Presentation at the 50th Annual Meeting of the American Society of Hematology 5Health News:Keryx Biopharmaceuticals' KRX-0401 (Perifosine) Data Selected for Oral Presentation at the 50th Annual Meeting of the American Society of Hematology 6Health News:Joel Madden and Nicole Richie to Flip the Switch at the UNICEF and City of Beverly Hills 2008 Snowflake Lighting 2Health News:Polar Introduces the RS800CX Training Management System for Multisport Endurance Athletes 2Health News:Polar Introduces the RS800CX Training Management System for Multisport Endurance Athletes 3Health News:Polar Introduces the RS800CX Training Management System for Multisport Endurance Athletes 4Health News:Jonathan Jacobson Appointed General Manager, Global Business Strategies & Operations, Menicon Co., Ltd. 2
(Date:11/6/2009)..., ST. LOUIS, Nov. 6 R...tinued to depress sales for Allied Healthcare Prod...ng September 30, 2009. ,, Sales declines pushed... for the quarter was about $745,000, or negative 9...r earlier of about $208,000, or 3 cents per share....
(Date:11/6/2009)..., WILMINGTON, Mass., Nov. 6 /PRNewswire-FirstCa...GM: DUSA), a dermatology company that is developin...py (PDT) and other products focused on patients wi...n, President and Chief Executive Officer, will pre...ord Investor Summit 2009 on Tuesday, November 10, ...
(Date:11/6/2009)..., MORRISTOWN, N.J., Nov. 6 /PRNewswire-FirstCal...a leading specialty pharmaceutical company, announ... chief executive officer, will provide an overview...t Suisse 18th Annual Healthcare Conference on Wedn...ard Time. ,, This presentation will be webcast ...
Breaking Medicine Technology:Recession Continues to Depress Sales at Allied Healthcare Products 2Recession Continues to Depress Sales at Allied Healthcare Products 3Recession Continues to Depress Sales at Allied Healthcare Products 4Recession Continues to Depress Sales at Allied Healthcare Products 5Recession Continues to Depress Sales at Allied Healthcare Products 6Precuneus region of human and monkey brain is divided into 4 distinct regions 60531 1Innovative R 26amp 3BD prioritization tool earns Baxter the 2009 INFORMS Decision Analysis Award 10602 1Innovative R 26amp 3BD prioritization tool earns Baxter the 2009 INFORMS Decision Analysis Award 10602 2North Atlantic fish populations shifting as ocean temperatures warm 10600 1North Atlantic fish populations shifting as ocean temperatures warm 10600 2North Atlantic fish populations shifting as ocean temperatures warm 10600 3
...nd Efficacy Data Reported Trial Enrol...CISCO, Calif., May 31 Sunesis,Pharmaceuticals, In...nterim,data from the company,s ongoing Phase 2 cli...in (formerly SNS-595), in platinum-resistant ovari... Clinical Oncology (ASCO),Annual Meeting in Chicag...
...vival Benefit With TORISEL Regardless of, Nephrec... Side Effects -, COLLEGEVILLE, Pa., May 31 Wyeth...), today announced results,of two new analyses of ...,rapamycin) inhibitor TORISEL(R) (temsirolimus), t...an overall survival compared with,interferon-alpha...
Other Medicine Technology:Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting 2Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting 3Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting 4Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting 5New Analyses Presented at ASCO Reaffirmed Efficacy and Safety of TORISEL in Patients With Advanced Kidney Cancer 2New Analyses Presented at ASCO Reaffirmed Efficacy and Safety of TORISEL in Patients With Advanced Kidney Cancer 3New Analyses Presented at ASCO Reaffirmed Efficacy and Safety of TORISEL in Patients With Advanced Kidney Cancer 4New Analyses Presented at ASCO Reaffirmed Efficacy and Safety of TORISEL in Patients With Advanced Kidney Cancer 5New Analyses Presented at ASCO Reaffirmed Efficacy and Safety of TORISEL in Patients With Advanced Kidney Cancer 6
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
Medicine Products: